Cutting-edge QA solutions, advanced treatment planning, intelligent software and new MR-linac data highlight depth and breadth of Elekta’s transformative oncology portfolio
NASHVILLE US — Thursday, July 26, 2018
At the 60th American Association of Physicists in Medicine (AAPM) Annual Meeting & Exhibition July 29 - August 2 in Nashville, Elekta will feature advanced quality assurance (QA) and treatment planning solutions that simplify the delivery of complex therapeutic treatment techniques, increasing accuracy, efficiency and confidence.
As the complexity of radiation therapy increases, the need to achieve stringent safety, efficacy and efficiency requirements places additional demands on clinics. With robust patient, machine and departmental solutions, Elekta helps clinics strengthen their QA portfolios with standardized, streamlined and automated QA procedures that assure these requirements are met for every patient and every treatment session.
ELEKTA QA示范将包括:
- AQUA,全面的质量管理解决方案,坐标和集中所有机器QA测试有助于管理这些测试要求的复杂性。
- iViewDose软件是一种基于杂志的内部分数,体内患者剂量测定溶液,在放射治疗期间提供必要的安全检查。
- 端到端立体定向质量保证服务,一种使用Vivo PseudoPatient™技术的解决187金宝搏beat亚洲体育方案,使诊所能够加速其立体定向计划的实施,并优化治疗策略和协议。Elekta签署了与RTSafe的谅解备忘录,通过提高对立体定向系统的端到端准确性的置信度,并更广泛地获得先进的立体定向治疗,以优雅的QA解决188棋牌捕鱼方案提供优雅的QA解决方案。
对Elekta Booth#301的访问者还将有机会了解治疗计划和软件解决方案,包括:
- 摩纳哥®,先进的治疗规划系统,以真正的Monte Carlo准确度和高级多轨道优化提供更有效的高清计划。客户还可以预览我们的新摩纳哥社区,这是一个数字对等平台,允许客户共享高级应用程序,协议和最佳实践。
- Mosaiq.®与肿瘤学的Watson联合癌症护理和人工智能先驱Elekta和IB188棋牌捕鱼M Watson Health,为Elekta的癌症保健解决方案提供Watson。MOSAIQ支持基于价值的实践优化,并支持通过将大数据转化为管理癌症治疗的个性化,精确的方法来帮助超越癌症的临床决策。188棋牌捕鱼
- Leksell Gammaplan.®,伽马刀放射柜的综合治疗规划和管理软件,包括Leksell GammaKnife®icon™。
- onentra®brachy,a comprehensive brachytherapy treatment planning software that enables efficient treatment delivery workflows and optimal dose distribution.
MR-linac abstracts add to growing body of data
Elekta and its clinical collaborators will present 31 abstracts supporting the technical applications of its Elekta MR-linac, which received CE mark as Elekta Unity in June 2018 and enables magnetic resonance radiation therapy (MR/RT), an innovative and personalized application of radiation therapy to the treatment of cancer.
Abstracts presented at the conference include:
- Radiobiological Advantages of Motion Tracking for Liver, Pancreas, and Kidney SBRT Tumors in a MR-Linac (Tuesday, July 31, 1:45 – 3:45 p.m.) – Demonstrates the potential benefits of using the MR-linac tracking system to reduce radiation exposure of normal tissue and organs at risk, especially the kidney, bowels and duodenum.
- Implementing Retrospective Four-Dimensional Magnetic Resonance Imaging (4D-MRI) On An MR-Guided Linear Accelerator (MR-Linac): A Feasibility Study (Wednesday, August 1, 10:15 a.m. – 12:15 p.m.) – Describes the successful implementation of a 4D MRI technique on the MR-linac. This technique is a promising tool for improving the visualization and delineation of tumors that move during the course of a treatment session.
- Potential Dose Escalation for Pancreas SBRT Patients as a Result of Simulated Tumor Tracking and Margin Reduction in a MR-Linac (Tuesday, July 31, 3:45 – 4:15 p.m.) – Demonstrates the potential benefit of using the MR-linac tracking system to escalate the dose in patients receiving stereotactic body radiation therapy (SBRT) for the treatment of pancreatic cancer.
For real-time updates from the AAPM show floor, our educational events and annual Physics User Meeting, follow the Elekta Twitter handle,@Elekta. To learn more about Elekta at AAPM, visitwww.neump.com/aapm..
Elekta’s MR-linac has CE mark but is not available for commercial distribution or sale in the U.S.
###
关于Elekta.
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.neump.com